Sanofi to Invest $400 Million in Expanding Hyderabad Global Capacity Centre
7 Sources
[1]
Sanofi to inject €400 million by 2030 to expand its largest GCC in Hyderabad; to ramp up headcount to 2,600 by 2026 - Times of India
HYDERABAD: French biopharma giant Sanofi is injecting Euro 400 million (approx Rs 3,600 crore) in expanding its largest global capability centre (GCC) in Hyderabad by 2030 through its arm Sanofi Healthcare India Pvt Ltd. The initial tranche of Euro 100 million will be invested by 2025 in Hyderabad
[2]
Sanofi looking to expand India hub with Rs 3.6k-cr push
Hyderabad: French drugmaker Sanofi plans to invest ₹400 million (about ₹3,600 crore) over the next six years to expand its global capability centre (GCC) in Hyderabad by increasing the headcount and further developing the facility. Of the total, ₹100 million will be invested by the end of 2025.
[3]
Sanofi Healthcare India to invest €400 million in expanding Hyderabad's GCC
Sanofi Healthcare India Pvt. Ltd. (SHIPL) plans to invest €400 million in capacity expansion of its Global Capability Centre (GCC), Hyderabad including €100 million by 2025. Over the next two years, the GCC will expand to host up to 2600 employees, making it the largest of Sanofi's four global
[4]
Sanofi to expand its Global Capacity Centre in Hyderabad
Sanofi carries out more than 60 percent of its global production in the European Union. (Image Credits: Reuters) Sanofi Healthcare India Pvt. Ltd. (SHIPL) on Wednesday announced the expansion of its Global Capacity Centre (GCC) in Hyderabad, with plans to invest €400 million over the next six
[5]
French pharma giant Sanofi expands GCC in Hyderabad, to create 1,600 more jobs by 2026
French pharmaceutical giant Sanofi, through one of its entities in India, is expanding its Global Capacity Centre (GCC) in Hyderabad with an investment of Euro 400 million (about Rs. 3,600 crore) spread over six years and create additional 1,600 jobs at the facility in the next two years. The
[6]
Sanofi to invest $437 million in India global centre, double its workforce
HYDERABAD (Reuters) - French drugmaker Sanofi plans to invest 400 million euros ($437.24 million) in its global capacity centre (GCC) in India by the end of the decade, as it aims to expand and more than double its workforce over the next two years, a top company executive said on
[7]
Sanofi resets footprint in India, Hyd GCC to add new digital competencies
Frenehard spoke of the new capabilities, particularly around leveraging the power of AI. (Image Credits: Reuters) It was a new twist to a narrative from a healthcare company with conversations less about drug-making and more about digital transformation. It should have been expected, coming as it
Share
Copy Link
French pharmaceutical giant Sanofi announces a significant investment of $400 million to expand its Global Capacity Centre (GCC) in Hyderabad, India. The expansion aims to create 1,600 new jobs by 2026 and enhance the company's digital and data capabilities.
Sanofi's Major Investment in Hyderabad
French pharmaceutical company Sanofi has announced a substantial investment of $400 million (approximately ₹3,600 crore) to expand its Global Capacity Centre (GCC) in Hyderabad, India
1
. This strategic move is set to significantly boost the company's presence in India and create numerous job opportunities in the region.Expansion Plans and Job Creation
The expansion project is scheduled to be completed by 2030, with Sanofi planning to increase its workforce at the Hyderabad GCC from the current 1,000 employees to 2,600 by 2026
2
. This represents a substantial addition of 1,600 new jobs, primarily in areas such as digital, data, and analytics5
.Focus on Digital Transformation and Innovation
The investment aims to enhance Sanofi's digital and data capabilities, with a particular emphasis on developing artificial intelligence and machine learning solutions. The expanded GCC will play a crucial role in driving the company's global digital transformation efforts
3
.Strategic Importance of the Hyderabad GCC
Sanofi's Global Capacity Centre in Hyderabad, established in 2019, has rapidly grown to become the largest of the company's five GCCs worldwide. The centre supports Sanofi's global operations across various functions, including medical, clinical, regulatory, and digital
4
.Government Support and Economic Impact
The expansion project has received strong support from the Telangana government, which has promised to provide the necessary infrastructure and resources. This investment is expected to have a significant positive impact on the local economy and further solidify Hyderabad's position as a major pharmaceutical and technology hub
5
.Related Stories
Sanofi's Commitment to India
Sanofi's CEO, Paul Hudson, emphasized the company's long-term commitment to India, stating that the investment reflects their confidence in the country's talent pool and its potential to drive innovation in the healthcare sector
2
.Future Prospects
The expansion of Sanofi's Hyderabad GCC is expected to not only boost the company's global operations but also contribute significantly to the development of India's pharmaceutical and technology sectors. It underscores the growing importance of India in the global healthcare landscape and its potential to become a major hub for digital innovation in the pharmaceutical industry.
References
Summarized by
Navi
[4]
Related Stories
Recent Highlights
1
OpenAI's AI Math Breakthrough on Millennium Problem Sparks Fierce Attribution Battle
Science and Research
2
Trump Dismisses AI Regulation Calls, Targets Anthropic CEO Amid Growing Safety Concerns
Policy and Regulation
3
Nvidia CEO Jensen Huang Declares AGI Has Arrived With OpenAI's GPT-6 Astra Release
Technology
Recent Highlights
Today's Top Stories
Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Follow topics that matter to you and stay ahead.
